ID   TNS2_HUMAN              Reviewed;        1409 AA.
AC   Q63HR2; A2VDF2; A2VDF3; A2VDI8; A5PKY4; Q2NL80; Q76MW6; Q7Z5T9;
AC   Q8NFF9; Q8NFG0; Q96P25; Q9NT29; Q9UPS7;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 2.
DT   12-APR-2017, entry version 119.
DE   RecName: Full=Tensin-2;
DE            EC=3.1.3.-;
DE   AltName: Full=C1 domain-containing phosphatase and tensin homolog;
DE            Short=C1-TEN;
DE   AltName: Full=Tensin-like C1 domain-containing phosphatase;
GN   Name=TNS2; Synonyms=KIAA1075, TENC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), INTERACTION WITH AXL,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=12470648; DOI=10.1016/S0006-291X(02)02718-3;
RA   Hafizi S., Alindri F., Karlsson R., Dahlbaeck B.;
RT   "Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1
RT   domain-containing protein with homology to tensin.";
RL   Biochem. Biophys. Res. Commun. 299:793-800(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11792844; DOI=10.1073/pnas.022518699;
RA   Chen H., Duncan I.C., Bozorgchami H., Lo S.H.;
RT   "Tensin1 and a previously undocumented family member, tensin2,
RT   positively regulate cell migration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:733-738(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 759-1409 (ISOFORM 6).
RC   TISSUE=Colon endothelium, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 364-1398 (ISOFORM 2).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF CYS-231.
RX   PubMed=15817639; DOI=10.1096/fj.04-2532fje;
RA   Hafizi S., Ibraimi F., Dahlbaeck B.;
RT   "C1-TEN is a negative regulator of the Akt/PKB signal transduction
RT   pathway and inhibits cell survival, proliferation, and migration.";
RL   FASEB J. 19:971-973(2005).
RN   [8]
RP   INTERACTION WITH SYK, AND SUBCELLULAR LOCATION.
RX   PubMed=22019427; DOI=10.1016/j.bbamcr.2011.10.001;
RA   Moon K.D., Zhang X., Zhou Q., Geahlen R.L.;
RT   "The protein-tyrosine kinase Syk interacts with the C-terminal region
RT   of tensin2.";
RL   Biochim. Biophys. Acta 1823:199-205(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120; SER-835 AND
RP   SER-1003, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-91; SER-120; SER-455;
RP   TYR-456; SER-466; THR-474; SER-820; SER-825; SER-830; SER-832;
RP   SER-845; SER-931; SER-941; SER-972; THR-977; SER-991; SER-1003;
RP   THR-1182 AND SER-1247, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   STRUCTURE BY NMR OF 1263-1409.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the PTB domain of KIAA1075 protein from
RT   human.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: Regulates cell motility and proliferation. May have
CC       phosphatase activity. Reduces AKT1 phosphorylation. Lowers AKT1
CC       kinase activity and interferes with AKT1 signaling.
CC       {ECO:0000269|PubMed:15817639}.
CC   -!- SUBUNIT: Interacts with AXL. Interacts with SYK; leading to its
CC       phosphorylation (PubMed:22019427). {ECO:0000269|PubMed:12470648,
CC       ECO:0000269|PubMed:22019427}.
CC   -!- INTERACTION:
CC       Q9NWL9:-; NbExp=3; IntAct=EBI-949753, EBI-10315054;
CC       Q6NUJ2:C11orf87; NbExp=3; IntAct=EBI-949753, EBI-6660291;
CC       P04626:ERBB2; NbExp=4; IntAct=EBI-949753, EBI-641062;
CC       P21860:ERBB3; NbExp=3; IntAct=EBI-949753, EBI-720706;
CC       P10721:KIT; NbExp=2; IntAct=EBI-949753, EBI-1379503;
CC       Q5T749:KPRP; NbExp=6; IntAct=EBI-949753, EBI-10981970;
CC       P60370:KRTAP10-5; NbExp=3; IntAct=EBI-949753, EBI-10172150;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-949753, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-949753, EBI-10171774;
CC       P59991:KRTAP12-2; NbExp=5; IntAct=EBI-949753, EBI-10176379;
CC       P08581:MET; NbExp=2; IntAct=EBI-949753, EBI-1039152;
CC       Q9Y5Y2:NUBP2; NbExp=3; IntAct=EBI-949753, EBI-1048886;
CC       P32242:OTX1; NbExp=6; IntAct=EBI-949753, EBI-740446;
CC       Q13835:PKP1; NbExp=3; IntAct=EBI-949753, EBI-2513407;
CC       Q96HR9:REEP6; NbExp=5; IntAct=EBI-949753, EBI-750345;
CC       Q04864:REL; NbExp=3; IntAct=EBI-949753, EBI-307352;
CC       Q9NUL5:RYDEN; NbExp=4; IntAct=EBI-949753, EBI-10313866;
CC       Q96M29:TEKT5; NbExp=5; IntAct=EBI-949753, EBI-10239812;
CC       P15622-3:ZNF250; NbExp=3; IntAct=EBI-949753, EBI-10177272;
CC       Q8TAU3:ZNF417; NbExp=5; IntAct=EBI-949753, EBI-740727;
CC       Q6ZNH5:ZNF497; NbExp=4; IntAct=EBI-949753, EBI-10486136;
CC       Q96SQ5:ZNF587; NbExp=7; IntAct=EBI-949753, EBI-6427977;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:11792844, ECO:0000269|PubMed:22019427}. Cell
CC       membrane {ECO:0000269|PubMed:11792844}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:11792844}; Cytoplasmic side
CC       {ECO:0000269|PubMed:11792844}. Note=Detected at the end of actin
CC       stress fibers. Detected in cytoplasmic punctate bodies
CC       (PubMed:22019427). {ECO:0000269|PubMed:22019427}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q63HR2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q63HR2-2; Sequence=VSP_026460;
CC       Name=4;
CC         IsoId=Q63HR2-4; Sequence=VSP_026458;
CC       Name=5;
CC         IsoId=Q63HR2-5; Sequence=VSP_026457;
CC       Name=6;
CC         IsoId=Q63HR2-6; Sequence=VSP_026461;
CC   -!- TISSUE SPECIFICITY: Detected in heart, kidney, brain, thymus,
CC       spleen, liver, placenta, lung, skeletal muscle and small
CC       intestine. {ECO:0000269|PubMed:11792844,
CC       ECO:0000269|PubMed:12470648}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI29829.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI29830.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI31504.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA83027.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAH56176.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF518729; AAM74225.1; -; mRNA.
DR   EMBL; AF518728; AAN03866.1; -; mRNA.
DR   EMBL; AF417490; AAL14641.1; -; mRNA.
DR   EMBL; AB028998; BAA83027.2; ALT_INIT; mRNA.
DR   EMBL; AL137564; CAB70815.1; -; mRNA.
DR   EMBL; BX647126; CAH56176.1; ALT_SEQ; mRNA.
DR   EMBL; BC054099; AAH54099.1; -; mRNA.
DR   EMBL; BC110854; AAI10855.1; -; mRNA.
DR   EMBL; BC129828; AAI29829.1; ALT_INIT; mRNA.
DR   EMBL; BC129829; AAI29830.1; ALT_INIT; mRNA.
DR   EMBL; BC131503; AAI31504.1; ALT_INIT; mRNA.
DR   EMBL; BC142668; AAI42669.1; -; mRNA.
DR   EMBL; BC142712; AAI42713.1; -; mRNA.
DR   CCDS; CCDS8842.1; -. [Q63HR2-4]
DR   CCDS; CCDS8843.1; -. [Q63HR2-1]
DR   CCDS; CCDS8844.1; -. [Q63HR2-5]
DR   PIR; T46500; T46500.
DR   RefSeq; NP_056134.2; NM_015319.2. [Q63HR2-4]
DR   RefSeq; NP_736610.2; NM_170754.2. [Q63HR2-1]
DR   RefSeq; NP_938072.1; NM_198316.1. [Q63HR2-5]
DR   UniGene; Hs.343334; -.
DR   UniGene; Hs.6147; -.
DR   PDB; 2DKQ; NMR; -; A=1263-1409.
DR   PDB; 2KNO; NMR; -; A=1135-1249.
DR   PDB; 2L6K; NMR; -; A=1135-1248.
DR   PDB; 2LOZ; NMR; -; A=1263-1409.
DR   PDB; 3HQC; X-ray; 1.80 A; A=1264-1409.
DR   PDBsum; 2DKQ; -.
DR   PDBsum; 2KNO; -.
DR   PDBsum; 2L6K; -.
DR   PDBsum; 2LOZ; -.
DR   PDBsum; 3HQC; -.
DR   ProteinModelPortal; Q63HR2; -.
DR   SMR; Q63HR2; -.
DR   BioGrid; 116951; 74.
DR   IntAct; Q63HR2; 132.
DR   MINT; MINT-2870924; -.
DR   STRING; 9606.ENSP00000319756; -.
DR   DEPOD; Q63HR2; -.
DR   iPTMnet; Q63HR2; -.
DR   PhosphoSitePlus; Q63HR2; -.
DR   BioMuta; TENC1; -.
DR   DMDM; 150416153; -.
DR   EPD; Q63HR2; -.
DR   MaxQB; Q63HR2; -.
DR   PaxDb; Q63HR2; -.
DR   PeptideAtlas; Q63HR2; -.
DR   PRIDE; Q63HR2; -.
DR   DNASU; 23371; -.
DR   Ensembl; ENST00000314250; ENSP00000319684; ENSG00000111077. [Q63HR2-1]
DR   Ensembl; ENST00000314276; ENSP00000319756; ENSG00000111077. [Q63HR2-4]
DR   Ensembl; ENST00000379902; ENSP00000369232; ENSG00000111077. [Q63HR2-5]
DR   Ensembl; ENST00000546602; ENSP00000449363; ENSG00000111077. [Q63HR2-2]
DR   Ensembl; ENST00000552570; ENSP00000447021; ENSG00000111077. [Q63HR2-6]
DR   GeneID; 23371; -.
DR   KEGG; hsa:23371; -.
DR   UCSC; uc001sbl.4; human. [Q63HR2-1]
DR   CTD; 23371; -.
DR   DisGeNET; 23371; -.
DR   GeneCards; TNS2; -.
DR   HGNC; HGNC:19737; TNS2.
DR   HPA; HPA034659; -.
DR   MIM; 607717; gene.
DR   neXtProt; NX_Q63HR2; -.
DR   OpenTargets; ENSG00000111077; -.
DR   PharmGKB; PA134976096; -.
DR   eggNOG; KOG1930; Eukaryota.
DR   eggNOG; KOG2283; Eukaryota.
DR   eggNOG; ENOG410YFRV; LUCA.
DR   GeneTree; ENSGT00760000119113; -.
DR   HOVERGEN; HBG108559; -.
DR   InParanoid; Q63HR2; -.
DR   KO; K18080; -.
DR   OMA; RQGYREP; -.
DR   OrthoDB; EOG091G00II; -.
DR   PhylomeDB; Q63HR2; -.
DR   TreeFam; TF315996; -.
DR   SignaLink; Q63HR2; -.
DR   ChiTaRS; TENC1; human.
DR   EvolutionaryTrace; Q63HR2; -.
DR   GeneWiki; TENC1; -.
DR   GenomeRNAi; 23371; -.
DR   PRO; PR:Q63HR2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111077; -.
DR   ExpressionAtlas; Q63HR2; baseline and differential.
DR   Genevisible; Q63HR2; HS.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019725; P:cellular homeostasis; IEA:Ensembl.
DR   GO; GO:0032963; P:collagen metabolic process; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0048871; P:multicellular organismal homeostasis; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0014850; P:response to muscle activity; IEA:Ensembl.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01213; PTB_tensin; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR013625; PTB.
DR   InterPro; IPR006020; PTB/PI_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR014020; Tensin_C2-dom.
DR   InterPro; IPR029023; Tensin_phosphatase.
DR   InterPro; IPR033929; Tensin_PTB.
DR   Pfam; PF08416; PTB; 1.
DR   Pfam; PF10409; PTEN_C2; 1.
DR   Pfam; PF00017; SH2; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00462; PTB; 1.
DR   SMART; SM01326; PTEN_C2; 1.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS51182; C2_TENSIN; 1.
DR   PROSITE; PS51181; PPASE_TENSIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Hydrolase; Membrane; Metal-binding; Methylation;
KW   Phosphoprotein; Polymorphism; Protein phosphatase; Reference proteome;
KW   SH2 domain; Zinc; Zinc-finger.
FT   CHAIN         1   1409       Tensin-2.
FT                                /FTId=PRO_0000292987.
FT   DOMAIN      122    294       Phosphatase tensin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00590}.
FT   DOMAIN      299    425       C2 tensin-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00589}.
FT   DOMAIN     1140   1247       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   ZN_FING      31     79       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   COMPBIAS    489    533       Pro-rich.
FT   COMPBIAS    724   1122       Pro-rich.
FT   ACT_SITE    231    231       Phosphocysteine intermediate.
FT                                {ECO:0000305}.
FT   MOD_RES      91     91       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CGB6}.
FT   MOD_RES     120    120       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     455    455       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     456    456       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     474    474       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     481    481       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CGB6}.
FT   MOD_RES     483    483       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8CGB6}.
FT   MOD_RES     555    555       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q8CGB6}.
FT   MOD_RES     820    820       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     825    825       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     830    830       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     832    832       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     835    835       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     845    845       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     910    910       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8CGB6}.
FT   MOD_RES     931    931       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     941    941       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     972    972       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     977    977       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     991    991       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1003   1003       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1182   1182       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1247   1247       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    124       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11792844,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026457.
FT   VAR_SEQ       1     25       MKSSGPVERLLRALGRRDSSRAASR -> MDGGGVCVGRGD
FT                                LLSSPQALGQLLRKESRPRRAMK (in isoform 4).
FT                                {ECO:0000303|PubMed:12470648}.
FT                                /FTId=VSP_026458.
FT   VAR_SEQ     776    872       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026460.
FT   VAR_SEQ    1273   1274       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_026461.
FT   VARIANT     353    353       S -> T (in dbSNP:rs11170389).
FT                                /FTId=VAR_033043.
FT   VARIANT     670    670       A -> T (in dbSNP:rs11558984).
FT                                /FTId=VAR_052547.
FT   MUTAGEN     231    231       C->S: Abolishes inhibition of AKT1 kinase
FT                                activity. {ECO:0000269|PubMed:15817639}.
FT   CONFLICT    702    702       A -> V (in Ref. 6; AAH54099).
FT                                {ECO:0000305}.
FT   CONFLICT    898    898       P -> Q (in Ref. 6; AAH54099).
FT                                {ECO:0000305}.
FT   CONFLICT   1036   1036       P -> L (in Ref. 5; CAB70815).
FT                                {ECO:0000305}.
FT   CONFLICT   1083   1083       G -> E (in Ref. 6; AAI29830).
FT                                {ECO:0000305}.
FT   CONFLICT   1119   1119       P -> S (in Ref. 6; AAH54099).
FT                                {ECO:0000305}.
FT   CONFLICT   1148   1148       D -> G (in Ref. 6; AAH54099).
FT                                {ECO:0000305}.
FT   CONFLICT   1236   1236       P -> L (in Ref. 5; CAH56176).
FT                                {ECO:0000305}.
FT   CONFLICT   1246   1246       P -> L (in Ref. 1; AAM74225/AAN03866, 2;
FT                                AAL14641 and 3; BAA83027). {ECO:0000305}.
FT   HELIX      1137   1140       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1141   1144       {ECO:0000244|PDB:2L6K}.
FT   HELIX      1147   1154       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1161   1166       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1168   1170       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1173   1179       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1184   1189       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1190   1192       {ECO:0000244|PDB:2L6K}.
FT   HELIX      1194   1198       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1199   1205       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1210   1213       {ECO:0000244|PDB:2L6K}.
FT   STRAND     1222   1224       {ECO:0000244|PDB:2L6K}.
FT   HELIX      1225   1230       {ECO:0000244|PDB:2KNO}.
FT   TURN       1231   1234       {ECO:0000244|PDB:2KNO}.
FT   STRAND     1237   1241       {ECO:0000244|PDB:2L6K}.
FT   HELIX      1266   1272       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1274   1285       {ECO:0000244|PDB:3HQC}.
FT   HELIX      1291   1304       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1305   1307       {ECO:0000244|PDB:2DKQ}.
FT   STRAND     1312   1319       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1322   1329       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1332   1339       {ECO:0000244|PDB:3HQC}.
FT   HELIX      1340   1342       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1343   1348       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1350   1352       {ECO:0000244|PDB:2LOZ}.
FT   STRAND     1354   1356       {ECO:0000244|PDB:3HQC}.
FT   TURN       1358   1360       {ECO:0000244|PDB:2DKQ}.
FT   STRAND     1362   1372       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1375   1385       {ECO:0000244|PDB:3HQC}.
FT   STRAND     1389   1391       {ECO:0000244|PDB:2DKQ}.
FT   HELIX      1393   1405       {ECO:0000244|PDB:3HQC}.
SQ   SEQUENCE   1409 AA;  152580 MW;  67824299A1382140 CRC64;
     MKSSGPVERL LRALGRRDSS RAASRPRKAE PHSFREKVFR KKPPVCAVCK VTIDGTGVSC
     RVCKVATHRK CEAKVTSACQ ALPPVELRRN TAPVRRIEHL GSTKSLNHSK QRSTLPRSFS
     LDPLMERRWD LDLTYVTERI LAAAFPARPD EQRHRGHLRE LAHVLQSKHR DKYLLFNLSE
     KRHDLTRLNP KVQDFGWPEL HAPPLDKLCS ICKAMETWLS ADPQHVVVLY CKGNKGKLGV
     IVSAYMHYSK ISAGADQALA TLTMRKFCED KVATELQPSQ RRYISYFSGL LSGSIRMNSS
     PLFLHYVLIP MLPAFEPGTG FQPFLKIYQS MQLVYTSGVY HIAGPGPQQL CISLEPALLL
     KGDVMVTCYH KGGRGTDRTL VFRVQFHTCT IHGPQLTFPK DQLDEAWTDE RFPFQASVEF
     VFSSSPEKIK GSTPRNDPSV SVDYNTTEPA VRWDSYENFN QHHEDSVDGS LTHTRGPLDG
     SPYAQVQRPP RQTPPAPSPE PPPPPMLSVS SDSGHSSTLT TEPAAESPGR PPPTAAERQE
     LDRLLGGCGV ASGGRGAGRE TAILDDEEQP TVGGGPHLGV YPGHRPGLSR HCSCRQGYRE
     PCGVPNGGYY RPEGTLERRR LAYGGYEGSP QGYAEASMEK RRLCRSLSEG LYPYPPEMGK
     PATGDFGYRA PGYREVVILE DPGLPALYPC PACEEKLALP TAALYGLRLE REAGEGWASE
     AGKPLLHPVR PGHPLPLLLP ACGHHHAPMP DYSCLKPPKA GEEGHEGCSY TMCPEGRYGH
     PGYPALVTYS YGGAVPSYCP AYGRVPHSCG SPGEGRGYPS PGAHSPRAGS ISPGSPPYPQ
     SRKLSYEIPT EEGGDRYPLP GHLASAGPLA SAESLEPVSW REGPSGHSTL PRSPRDAPCS
     ASSELSGPST PLHTSSPVQG KESTRRQDTR SPTSAPTQRL SPGEALPPVS QAGTGKAPEL
     PSGSGPEPLA PSPVSPTFPP SSPSDWPQER SPGGHSDGAS PRSPVPTTLP GLRHAPWQGP
     RGPPDSPDGS PLTPVPSQMP WLVASPEPPQ SSPTPAFPLA ASYDTNGLSQ PPLPEKRHLP
     GPGQQPGPWG PEQASSPARG ISHHVTFAPL LSDNVPQTPE PPTQESQSNV KFVQDTSKFW
     YKPHLSRDQA IALLKDKDPG AFLIRDSHSF QGAYGLALKV ATPPPSAQPW KGDPVEQLVR
     HFLIETGPKG VKIKGCPSEP YFGSLSALVS QHSISPISLP CCLRIPSKDP LEETPEAPVP
     TNMSTAADLL RQGAACSVLY LTSVETESLT GPQAVARASS AALSCSPRPT PAVVHFKVSA
     QGITLTDNQR KLFFRRHYPV NSITFSSTDP QDRRWTNPDG TTSKIFGFVA KKPGSPWENV
     CHLFAELDPD QPAGAIVTFI TKVLLGQRK
//
